Novel euglycemic and hypolipidemic agents. 1

被引：81

作者：

Lohray, BB ^{[1
]}

Bhusan, V ^{[1
]}

Rao, BP ^{[1
]}

Medhavan, GR ^{[1
]}

Murali, N ^{[1
]}

Rao, KN ^{[1
]}

Reddy, AK ^{[1
]}

Rajesh, BM ^{[1
]}

Reddy, PG ^{[1
]}

Chakrabarti, R ^{[1
]}

Vikramadithyan, RK ^{[1
]}

Rajagopalan, R ^{[1
]}

Mamidi, RNVS ^{[1
]}

Jajoo, HK ^{[1
]}

Subramanian, S ^{[1
]}

机构：

[1] Dr Reddys Res Fdn, Hyderabad 500050, Andhra Pradesh, India

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1998年 / 41卷 / 10期

关键词：

D O I：

10.1021/jm970444e

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of [[(heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinediones have been synthesized by the condensation of corresponding aldehyde 1 and 2,4-thiazolidinedione followed by hydrogenation. Both unsaturated thiazolidinedione 2 and its saturated counterpart 3 have shown antihyperglycemic activity. Many of these compounds have shown superior euglycemic and hypolipidemic activity compared to troglitazone (CS 045). The indole analogue DRF-2189 (3g) was found to be a very potent insulin sensitizer, comparable to BRL-49653 in genetically obese C57BL/6J-ob/ob and 57BL/KsJ-db/db mice. Pharmacokinetic and tissue distribution studies conducted on BRL-49653 and DRF-2189 (3g) indicate that these drugs are well-distributed in target tissues. On the basis of euglycemic activity as well as enhanced selectivity against reduction of triglycerides in plasma, DRF-2189 (3g) has been selected for further evaluation.

引用

页码：1619 / 1630

页数：12

共 50 条

[31] Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents.
Giri, Smith
Huntington, Scott F.
Wang, Rong
Zeidan, Amer Methqal
Podoltsev, Nikolai Alexandrovich
Gore, Steven
Ma, Xiaomei
Gross, Cary Philip
Davidoff, Amy J.
Neparidze, Natalia
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[32] Novel benzoxazocine analogues as potent analgesic agents.
Baxter, AD
Lyne, M
Brown, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U106 - U107
[33] Using chemical ecology to find novel antifungal agents.
Eckerman, SJ
Graham, KJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U254 - U254
[34] A novel series of low molecular weight immunosuppressive agents.
Ocain, TD
Bastos, CM
Gordon, K
Granstein, R
Jenson, JC
Jones, B
McAuliffe, D
Newcomb, J
Sampo, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 244 - MEDI
[35] 9,11-methylidenerythromycins: Novel prokinetic agents.
Schultz, CC
Faghih, R
Nellans, HN
Buckner, SA
Lartey, PA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 204 - MEDI
[36] Synthesis of novel tetracyclic benzothiazepines as potential antifungal agents.
Peesapati, V
Sreelakshmi, P
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U16 - U16
[37] Novel bicyclic oxazolone and oxazolone derivatives as antiangiogenic agents.
PerronSierra, FM
Guyard, C
Billington, DC
Atassi, G
Pierre, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 147 - MEDI
[38] Discovery and characterization of novel natural cancer chemopreventive agents.
Pezzulo, JM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U366 - U366
[39] Avicins: A novel class of anti-myeloma agents.
Mitsiades, N
McMullan, CJ
Poulabi, V
Negri, J
Geer, DC
Haridas, V
Munshi, NC
Gutterman, J
Anderson, KC
Mitsiades, CS
BLOOD, 2004, 104 (11) : 929A - 929A
[40] Design and synthesis of novel β-lactams as potential antimicrobial agents.
Amry, A
McCain, M
Konaklieva, M
Plotkin, B
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U13 - U13

← 1 2 3 4 5 →